BlueGenes - 3x3x3 Challenge with Nick Glimcher
BlueGenes streamlines pharmacogenetics by integrating with pharmacy benefit managers to prevent ineffective prescriptions in real time, improving treatment precision for self-insured and state-funded health plans.
Transcript:
What is BlueGenes?
BlueGenes is a pharmacogenetic platform. For those of you that don't know, pharmacogenetics is simply the science of what drugs work and what drugs don't. We are our own laboratory, so we perform our tests in-house, but the test itself is a complete commodity. There are many laboratories capable of running a genetic test. What BlueGenes does is it tackles the primary problem with pharmacogenetics and that's that it doesn't fit in the provider's clinical workflows, and the information lends itself to obsolescence by virtue of the fact that the test is once in a lifetime. There are no providers in the United States that are looking at PGX tests to make clinical prescribing decisions that are, say, 5 or 10 years old, and most new providers are either unwilling or unable to find this information. For pharmacogenetics to be used and applicable, we must have access to the information.
How is BlueGenes different?
BlueGenes is the only platform out there that can integrate with the pharmacy benefit manager to create a real-time claim denial. So when the patient goes to see the doctor, as they always have, they will be prescribed medicine and will leave the EMR and it will go to the PBM for insurance verification. When it gets to the PBM, the PBM is able to recognize the member's BlueGenes by a patient identifier code, an organization code and other authenticating factors such as birth date, and it sends us claims data in real time. Our system is able to query that against a stored patient test profile and in less than one second create a claim denial if the medication itself is not efficacious for a patient based on their genetics. So the reason why we're having a lot of success is we don't require any behavioral change. The patient does not even need to remember that they ever took a genetic test. And for the provider, we simply feel like a coverage determination or prior authorization denial, and they don't love those, but they're used to dealing with them in their daily workflow.
Who is a good fit for BlueGenes?
All self-insured plans, all state plans, state funded plans, all federal plans are all good targets for BlueGenes. We typically like to work with plans that there is either integration present or an integration underway with the particular PBM, but we take all plans that are interested in precision medicine.
Transcript:
What is BlueGenes?
BlueGenes is a pharmacogenetic platform. For those of you that don't know, pharmacogenetics is simply the science of what drugs work and what drugs don't. We are our own laboratory, so we perform our tests in-house, but the test itself is a complete commodity. There are many laboratories capable of running a genetic test. What BlueGenes does is it tackles the primary problem with pharmacogenetics and that's that it doesn't fit in the provider's clinical workflows, and the information lends itself to obsolescence by virtue of the fact that the test is once in a lifetime. There are no providers in the United States that are looking at PGX tests to make clinical prescribing decisions that are, say, 5 or 10 years old, and most new providers are either unwilling or unable to find this information. For pharmacogenetics to be used and applicable, we must have access to the information.
How is BlueGenes different?
BlueGenes is the only platform out there that can integrate with the pharmacy benefit manager to create a real-time claim denial. So when the patient goes to see the doctor, as they always have, they will be prescribed medicine and will leave the EMR and it will go to the PBM for insurance verification. When it gets to the PBM, the PBM is able to recognize the member's BlueGenes by a patient identifier code, an organization code and other authenticating factors such as birth date, and it sends us claims data in real time. Our system is able to query that against a stored patient test profile and in less than one second create a claim denial if the medication itself is not efficacious for a patient based on their genetics. So the reason why we're having a lot of success is we don't require any behavioral change. The patient does not even need to remember that they ever took a genetic test. And for the provider, we simply feel like a coverage determination or prior authorization denial, and they don't love those, but they're used to dealing with them in their daily workflow.
Who is a good fit for BlueGenes?
All self-insured plans, all state plans, state funded plans, all federal plans are all good targets for BlueGenes. We typically like to work with plans that there is either integration present or an integration underway with the particular PBM, but we take all plans that are interested in precision medicine.